ÂÜÀòÂÒÂ×

Dr. Ramzi Melhem, MD serves as Medical Director, Oncology at Phanes Therapeutics. Dr. Melhem supports clinical development functions at Phanes, working with the Research and Process Development teams to advance Phanes’ lead molecules into Phase I studies. He serves as a medical monitor for Phanes clinical studies and manages relationships with the clinical investigators/sites.

Dr. Melhem has broad and in-depth experience in clinical development and operations, from the early phase to expansive global studies. Prior to joining Phanes, he served as Medical Director at Senseibio. There he led the clinical development of an immunophage, first of its kind cancer vaccine, and the immuno-oncology clinical group. He has spent more than 10 years in the pharmaceutical/biotechnology industry holding leadership positions of increasing responsibility at CROs managing several sponsor studies and investigative sites.

Dr. Melhem earned his B.S. in Biology and Doctorate of Medicine MD from the American University of Beirut. He completed his Post-Doctoral Fellowship at the University of California, Davis.